Generate Biomedicines, Inc. (GENB) Institutional Ownership Changes & 13F Activity

Generate Biomedicines, Inc. (GENB). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Deep Track Capital, Lp, Fmr Llc, Vanguard Capital Management Llc, ARK Invest, and Millennium Management Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheBuy+10,491+14.1%84,803$1.43MQ2 2026Sep 09, 2026
California State Teachers Retirement SystemBuy+336336$5.67KQ2 2026Aug 24, 2026
Deep Track Capital, LpBuy+1,333,8151,333,815$22.50MQ2 2026Aug 14, 2026
ARK InvestBuy+786,209+157.7%1,284,617$21.67MQ2 2026Aug 14, 2026
Millennium Management LlcSell-354,967-94.2%21,926$369.89KQ2 2026Aug 14, 2026
Braidwell LpSell-309,155-8.6%3,283,844$55.40MQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+224,602224,602$3.79MQ2 2026Aug 14, 2026
Goldman Sachs Group IncSell-159,512-93.4%11,183$188.66KQ2 2026Aug 14, 2026
Ameriprise Financial IncBuy+91,10091,100$1.54MQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Buy+60,000+32.4%245,000$4.13MQ2 2026Aug 14, 2026
Price T Rowe Associates IncBuy+46,994+2.2%2,156,627$36.38MQ2 2026Aug 14, 2026
Barclays PlcBuy+46,008+64.9%116,902$1.97MQ2 2026Aug 14, 2026
Xtx Topco LtdBuy+24,95624,956$421.01KQ2 2026Aug 14, 2026
Alliancebernstein L.P.Buy+22,65022,650$382.11KQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+22,102+1841.8%23,302$393.11KQ2 2026Aug 14, 2026
Bank Of America CorpBuy+21,234+62.1%55,430$935.10KQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+18,37418,374$309.97KQ2 2026Aug 14, 2026
Metlife Investment Management, LlcBuy+14,84114,841$250.37KQ2 2026Aug 14, 2026
Invesco Ltd.Buy+13,08713,087$220.78KQ2 2026Aug 14, 2026
Sei Investments CoBuy+12,08812,088$203.93KQ2 2026Aug 14, 2026
Susquehanna International Group, LlpBuy+11,62211,622$196.06KQ2 2026Aug 14, 2026
Mirae Asset Global Etfs Holdings Ltd.Buy+11,19311,193$188.83KQ2 2026Aug 14, 2026
Squarepoint Ops LlcSell-5,797-15.6%31,406$529.82KQ2 2026Aug 14, 2026
Legal & General Group PlcBuy+2,3742,374$40.04KQ2 2026Aug 14, 2026
Stance Capital LlcBuy+1,3841,384$23.35KQ2 2026Aug 14, 2026
Royal Bank Of CanadaBuy+1,150+497.8%1,381$23.00KQ2 2026Aug 14, 2026
Jones Financial Companies LllpBuy+200200$3.29KQ2 2026Aug 14, 2026
Fmr LlcBuy+1,004,075+23.8%5,221,599$88.09MQ2 2026Aug 13, 2026
Vanguard Capital Management LlcBuy+1,001,431+762.6%1,132,750$19.11MQ2 2026Aug 13, 2026
Davern Capital Partners, LpBuy+232,879+39.4%824,679$13.91MQ2 2026Aug 13, 2026
Showing 30 of 88

Frequently asked questions about GENB activity

  • Which institutional owners are buying GENB?

    Institutional owners buying GENB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in GENB activity?

    "Buy" means an investor increased their reported position in GENB compared to the prior reporting period. This reflects growing exposure to Generate Biomedicines, Inc. (GENB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in GENB increasing?

    Institutional interest in GENB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.